Call us today: +1 (304) 470-2225
English
You can use WPML or Polylang and their language switchers in this area.
0 $0.00

Cart

No products in the cart.

View Cart Checkout

Menu

Biosimilar

Home » Biosimilar
Humira-Competitive-Landscape-June-2023 Implications of the AVT02 (Humira Biosimilar) by Teva and Alvotech on the Humira Biosimilar Market

Implications of the AVT02 (Humira Biosimilar) by Teva and Alvotech on the Humira Biosimilar Market

Biosimilar by Mellalta Meets Analyst Leave a Comment on Implications of the AVT02 (Humira Biosimilar) by Teva and Alvotech on the Humira Biosimilar Market

The pending second Biologics License Application (BsUFA) for AVT02 (Humira biosimilar) by Teva and Alvotech, on June 28th, 2023 (Today), could dramatically alter the dynamics within the Humira biosimilar market. Anticipated approval of AVT02 by […]

Read More

Latest Cast Studies

Artificial Intelligence Diagnostic Tool–Due Diligence for Collaboration

Robot-Assisted Surgical System–MedTech Market Intelligence

Anti-Infective–Market Access Strategies 

Upcoming Events

Close Menu